Christina Coughlin

2020

In 2020, Christina Coughlin earned a total compensation of $2.5M as Chief Medical Officer at Rubius Therapeutics.

Compensation breakdown

Bonus$216,476
Option Awards$1,828,388
Salary$420,369
Other$58,242
Total$2,523,475

Coughlin received $1.8M in option awards, accounting for 72% of the total pay in 2020.

Coughlin also received $216.5K in bonus, $420.4K in salary and $58.2K in other compensation.

Rankings

In 2020, Christina Coughlin's compensation ranked 4,508th out of 13,090 executives tracked by ExecPay. In other words, Coughlin earned more than 65.6% of executives.

ClassificationRankingPercentile
All
4,508
out of 13,090
66th
Division
Manufacturing
1,821
out of 5,621
68th
Major group
Chemicals And Allied Products
705
out of 2,254
69th
Industry group
Drugs
604
out of 1,954
69th
Industry
Biological Products, Except Diagnostic Substances
141
out of 411
66th
Source: SEC filing on March 30, 2021.

Coughlin's colleagues

We found three more compensation records of executives who worked with Christina Coughlin at Rubius Therapeutics in 2020.

2020

Pablo Cagnoni

Rubius Therapeutics

Chief Executive Officer

2020

Laurence Turka

Rubius Therapeutics

Chief Scientific Officer

2020

Maiken Keson-Brookes

Rubius Therapeutics

Chief Legal Officer

News

In-depth

You may also like